EKSO · Insider Trading
Ekso Bionics Holdings, Inc. Common Stock
Every open-market purchase and sale reported by EKSO officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-20 | Jason C Jones | Chief Operating Officer | Buy | +1,308 | +$15.50K |
| 2026-03-20 | Jerome Wong | Chief Financial Officer | Buy | +1,308 | +$15.50K |
| 2026-02-20 | Daniel Asher | 10%+ Owner | Buy | +15,540 | +$191.16K |
| 2026-02-19 | Daniel Asher | 10%+ Owner | Buy | +1,200 | +$11.52K |
| 2026-02-17 | Daniel Asher | 10%+ Owner | Buy | +102,029 | +$970.07K |
| 2026-01-07 | Jason C Jones | Chief Operating Officer | Sell | −1,320 | −$12.21K |
| 2025-12-10 | Jerome Wong | Chief Financial Officer | Sell | −1,238 | −$5.82K |
| 2025-12-10 | Jason C Jones | Chief Operating Officer | Sell | −270 | −$1.27K |
| 2025-11-12 | Jason C Jones | Chief Operating Officer | Sell | −9,723 | −$46.67K |
| 2025-11-12 | Scott G. Davis | CEO | Sell | −23,315 | −$111.91K |
| 2025-11-12 | Jerome Wong | Chief Financial Officer | Sell | −11,288 | −$54.18K |
| 2025-11-07 | Jason C Jones | Chief Operating Officer | A | +15,000 | — |
| 2025-11-07 | Scott G. Davis | CEO | A | +80,000 | — |
| 2025-11-07 | Jerome Wong | Chief Financial Officer | A | +19,500 | — |
| 2025-05-19 | Corinna Lathan | Director | A | +236,202 | — |
| 2025-05-19 | Deborah Lafer Scher | Director | A | +236,202 | — |
| 2025-05-19 | Mary Ann Cloyd | Director | A | +236,202 | — |
| 2025-05-19 | Kecheng Li | Director | A | +236,202 | — |
| 2025-03-18 | Scott G. Davis | CEO | A | +5,590 | — |
| 2025-03-18 | Jason C Jones | Chief Operating Officer | A | +24,248 | — |
| 2025-03-18 | Jerome Wong | Chief Financial Officer | A | +24,248 | — |
| 2024-06-26 | Kecheng Li | Director | A | +78,217 | — |
| 2024-06-26 | Mary Ann Cloyd | Director | A | +78,217 | — |
| 2024-06-26 | Corinna Lathan | Director | A | +78,217 | — |
| 2024-06-26 | Deborah Lafer Scher | Director | A | +78,217 | — |
| 2024-04-04 | Jerome Wong | Chief Financial Officer | A | +7,474 | — |
| 2024-04-04 | Jason C Jones | Chief Operating Officer | A | +7,474 | — |
| 2024-04-04 | Jason C Jones | Chief Operating Officer | A | +14,246 | — |
| 2024-03-14 | Corinna Lathan | Director | Buy | +13,733 | +$15.48K |
| 2023-08-18 | Jerome Wong | Chief Financial Officer | Sell | −12,784 | −$12.73K |
| 2023-08-18 | Scott G. Davis | President & COO | Sell | −37,446 | −$37.28K |
| 2023-06-27 | Rhonda A. Wallen | Director | A | +67,392 | — |
| 2023-06-27 | Corinna Lathan | Director | A | +67,392 | — |
| 2023-06-27 | Steven Sherman | Executive Chair | A | +84,240 | — |
| 2023-06-27 | Kecheng Li | Director | A | +67,392 | — |
| 2023-06-27 | Mary Ann Cloyd | Director | A | +67,392 | — |
| 2023-06-16 | Corinna Lathan | Director | A | +72,993 | — |
| 2023-06-16 | Rhonda A. Wallen | Director | A | +72,993 | — |
| 2023-06-16 | Mary Ann Cloyd | Director | A | +72,993 | — |
| 2023-06-16 | Kecheng Li | Director | A | +72,993 | — |
| 2023-06-15 | Steven Sherman | Executive Chair | A | +91,241 | — |
| 2023-06-15 | Jason C Jones | Chief Operating Officer | A | +205,745 | — |
| 2023-06-15 | Jerome Wong | Chief Financial Officer | A | +178,268 | — |
| 2023-05-26 | Steven Sherman | Executive Chair | Sell | −45,660 | −$65.87K |
| 2023-05-17 | Jason C Jones | Chief Operating Officer | Sell | −3,435 | −$5.40K |
| 2023-05-17 | Steven Sherman | Executive Chair | M | +15,599 | — |
| 2022-12-07 | Steven Sherman | Executive Chair | MIXED | +263,301 | −$13.49K |
| 2022-12-06 | Jason C Jones | Senior VP Product Development | A | +17,007 | — |
| 2022-12-06 | Stanley Stern | Director | A | +87,787 | — |
| 2022-11-23 | Steven Sherman | CEO & Chairman | MIXED | +9,812 | −$7.31K |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Daniel Asher | 10%+ Owner | 435,432 | $5.14M |
| Scott G. Davis | CEO | 79,150 | $933.97K |
| Corinna Lathan | Director | 30,827 | $363.76K |
| Kecheng Li | Director | 30,729 | $362.60K |
| Mary Ann Cloyd | Director | 30,447 | $359.27K |
| Jason C Jones | Chief Operating Officer | 30,070 | $354.83K |
| Jerome Wong | Chief Financial Officer | 28,955 | $341.67K |
| Deborah Lafer Scher | Director | 20,961 | $247.34K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the EKSO quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.